Anti-CD80 monoclonal antibody: galiximab. Hematology Meeting Reports, [S. l.], v. 1, n. 8, 2009. DOI: 10.4081/hmr.v1i8.280. Disponível em: https://journals.pagepress.net/hmr/article/view/280. Acesso em: 3 jun. 2026.